Retinal and optic nerve diseases

被引:83
作者
Margalit, E
Sadda, TR
机构
[1] Univ So Calif, Keck Sch Med, Doheny Retina Inst, Los Angeles, CA 90033 USA
[2] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA
关键词
inner retina; outer retina; retinal degenerations; diabetic retinopathy; glaucoma; optic neuropathy; visual prostheses;
D O I
10.1046/j.1525-1594.2003.07304.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A variety of disease processes can affect the retina and/or the optic nerve. including vascular or ischemic disease. inflammatory or infectious disease, and degenerative disease. These disease processes may selectively damage certain parts of the retina or optic nerve, and the specific areas that are damaged may have implications for the design of potential therapeutic visual prosthetic devices. Outer retinal diseases include age-related macular degeneration, pathologic myopia, and retinitis pigmentosa. Although the retinal photoreceptors may be lost, the inner retina is relatively well-preserved in these diseases and may be a target for retinal prosthetic devices. Inner retinal diseases include retinal vascular diseases such as diabetic retinopathy. retinal venous occlusive disease, and retinopathy of prematurity. Other retinal diseases such as ocular infections (retinitis, endophthalmitis) may affect all retinal layers. Because the inner retinal cells, including the retinal ganglion cells, may be destroyed in these diseases (inner retinal or whole retinal), prosthetic devices that stimulate the inner retina may not be effective. Common optic nerve diseases include glaucoma, optic neuritis, and ischemic optic neuropathy. Because the ganglion cell nerve fibers themselves are damaged, visual prosthetics for these diseases will need to target more distal portions of the visual pathway, such as the visual cortex. Clearly, a sound understanding of retinal and optic nerve disease pathophysiology is critical for designing and choosing the optimal visual prosthetic device.
引用
收藏
页码:963 / 974
页数:12
相关论文
共 69 条
[1]  
[Anonymous], 1986, Arch Ophthalmol, V104, P34
[2]  
[Anonymous], 1990, Arch Ophthalmol, V108, P958
[3]  
[Anonymous], 1995, Arch Ophthalmol, V113, P1479
[4]  
[Anonymous], 1984, AM J OPHTHALMOL, V98, P271
[5]  
[Anonymous], 1981, OPHTHALMOLOGY, V88, P583
[6]  
ASHTON N, 1953, BR J OPHTHALMOL, V49, P225
[7]   THE EFFECT OF CORTICOSTEROIDS FOR ACUTE OPTIC NEURITIS ON THE SUBSEQUENT DEVELOPMENT OF MULTIPLE-SCLEROSIS [J].
BECK, RW ;
CLEARY, PA ;
TROBE, JD ;
KAUFMAN, DI ;
KUPERSMITH, MJ ;
PATY, DW ;
BROWN, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (24) :1764-1769
[8]  
Bennett J, 2000, CURR OPIN MOL THER, V2, P420
[9]  
BERI M, 1987, OPHTHALMOLOGY, V94, P1020
[10]   A RANDOMIZED TRIAL OF VITAMIN-A AND VITAMIN-E SUPPLEMENTATION FOR RETINITIS-PIGMENTOSA [J].
BERSON, EL ;
ROSNER, B ;
SANDBERG, MA ;
HAYES, KC ;
NICHOLSON, BW ;
WEIGELDIFRANCO, C ;
WILLETT, W .
ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (06) :761-772